DOD Pancreatic Cancer, Focused Pilot Award

Active
Yes
Status
Posted
Published Date
April 29th, 2024
Close Date
October 3rd, 2024
Total Funding
$1,280,000.00
Expected No. Awards
4
Opportunity No.
HT942524PCARPFPTA

Agency

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Pancreatic Cancer, Focused Pilot Award". This grant aims to support impactful and innovative concepts in pancreatic cancer research that can lead to significant advancements in patients' overall quality of life. The grant is focused on two patient-centered areas of research: access to healthcare and mental health/cancer-related outcomes and quality of life. The grant encourages studies on behaviors affecting access to healthcare, correlations between mental health and cancer outcomes, strategies to overcome psycho-social issues, behavioral studies on quality of life and decision-making, and development of nutritional or educational interventions for symptom management. The grant does not require preliminary data but expects a well-formulated, testable hypothesis based on strong scientific rationale. Clinical research studies are allowed, but interventional clinical trials, basic research, and preclinical animal studies are not supported. The proposed research should have a significant impact on improving outcomes and quality of life for individuals with pancreatic cancer. Innovation in study concept, research methods or technology, and adaptations of existing methods or technologies is highly encouraged. The grant has an estimated total program funding of $1,280,000 and expects to make 4 awards. The closing date for applications is October 3, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

Description

The PCARP Focused Pilot Award supports the exploration and development of impactful and innovative concepts under two patient-centered Focus Areas of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life.Examples of studies appropriate for the PCARP Focused Pilot Award include, but are not limited to:Investigations into behaviors that affect access to health care,Correlations between mental health and/or cancer-related outcomes and quality of life,Strategies to overcome psycho-social issues,Behavioral studies that examine quality of life, decision-making and/or cognitive function research,Development and pilot testing of nutritional or educational interventions, and symptom management.To foster advancement in these understudied areas of research, preliminary data is allowed, but not required. All projects should include a well-formulated, testable hypothesis based on strong scientific rationale. Research supported by this award should strive to produce robust preliminary data that can be used as a foundation for future clinical or real-world research application.Clinical research studies are allowed; however, interventional clinical trials are beyond the scope of this funding mechanism and will not be supported.Basic research and preclinical animal studies do not meet the intent of the Focused Pilot Award mechanism. Principal Investigators (PIs) seeking this funding for this type of research should utilize one of the other FY24 PCARP mechanisms.Significant features of the Focused Pilot Award include:Impact: The proposed research is expected to provide the scientific foundation that will ultimately lead to improved outcomes and quality of life for individuals with pancreatic cancer. The project’s impact on both pancreatic cancer patient-centered research and care should be articulated, even if clinical impact is not an immediate outcome.Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative.

Contact Information

Attachments
525 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

DOD Pancreatic Cancer, Idea Development Award
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DOD Pancreatic Cancer, Idea Development Award". This grant aims to support the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. The grant seeks to fund projects that make important and original contributions to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for patients. The research should be innovative and may challenge existing paradigms or utilize new perspectives, methods, or technologies. The grant encourages the inclusion of personnel with experience in pancreatic cancer research and the use of preliminary data to support the proposed research. Additionally, the grant offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. The deadline for application submission is October 3, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DOD Pancreatic Cancer, Translational Research Partnership Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant opportunity titled "DOD Pancreatic Cancer, Translational Research Partnership Award". This grant aims to support partnerships between clinicians and research scientists to accelerate the translation of promising ideas in pancreatic cancer towards clinical applications. The Translational Research Partnership Award seeks to foster collaborations between two independent investigators to address a central problem or question in pancreatic cancer that would be difficult to achieve through separate efforts. One partner in the collaboration must be a research scientist, while the other partner must be a clinician investigator. The award encourages the inclusion of experts from outside the pancreatic cancer field. The proposed projects should demonstrate the potential to have a significant impact on pancreatic cancer research and/or patient care. They should also leverage clinical information to address knowledge gaps, validate research findings, expand upon transformative results, and investigate novel findings. The application should provide evidence of the reciprocal transfer of information between basic and clinical science. The Translational Research Partnership Award requires the availability of necessary specimens, data, and/or interventions. Preliminary data relevant to pancreatic cancer and the proposed research project are required, although they do not necessarily need to be derived from studies of pancreatic cancer. The success of the project relies on the unique skills and contributions of each partner, and the proposed study must include plans for communication, coordination of research progress and results, and data transfer. This grant opportunity has an estimated total program funding of $4,800,000 and expects to make four awards. The closing date for applications is October 3, 2024. For more information and application submission requirements, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By providing a comprehensive summary of this federal grant notice, we hope to support potential applicants in understanding the purpose and requirements of the DOD Pancreatic Cancer, Translational Research Partnership Award.
DoD Ovarian Cancer Research Program Pilot Award
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Ovarian Cancer Research Program Pilot Award". This grant aims to support innovative concepts or theories in ovarian cancer research that could lead to critical discoveries or advancements in the field. The proposed research should focus on ovarian cancer using tissues, cell lines, datasets, or appropriate animal models. The grant seeks to expand or modify current thinking and approaches in ovarian cancer. The funding amount for this program is $4,800,000, and it is expected to award 10 grants. The deadline for application submission is August 6, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DOD Lung Cancer, Patient-Centered Outcomes and Survivorship Award
Dept. of the Army -- USAMRAA
The Dept. of the Army -- USAMRAA is offering a grant opportunity titled "DOD Lung Cancer, Patient-Centered Outcomes and Survivorship Award". This grant supports high-risk, high-reward research studies related to lung cancer. The research studies should focus on behavioral health science, survivorship, health outcomes, and comparative effectiveness research. The goal is to improve health and lung cancer-related outcomes and enhance the patient experience in defined populations. The grant aims to promote evidence-based and patient-centered approaches. Research studies may include examining and improving quality of life, decision-making, symptom and side effect management, prevention and diagnostics impact, and assessing the relationship between behavioral, cognitive, and social functioning in relation to lung cancer. The grant requires preliminary data for studies that propose active recruitment of human subjects and encourages the inclusion of a patient advocate in the research team. The close date for this grant opportunity is August 7, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.